Application of cell culture in studying antibacterial activity of rifampicin to Shigella and enteropathogenic Escherichia coli.
D000818:Animals; D002478:Cells, Cultured; D002701:Chloramphenicol / Q000494:pharmacology / Q000627:therapeutic use; D004926:Escherichia coli / Q000166:cytology / Q000187:drug effects* / Q000254:growth & development; D004927:Escherichia coli Infections / Q000188:drug therapy; D006367:HeLa Cells; D007612:Kanamycin / Q000494:pharmacology / Q000627:therapeutic use; D007739:L Cells; D008297:Male; D051379:Mice; D008826:Microbial Sensitivity Tests; D008858:Microscopy, Phase-Contrast; D012293:Rifampin / Q000494:pharmacology* / Q000627:therapeutic use; D012760:Shigella / Q000166:cytology / Q000187:drug effects* / Q000254:growth & development; D012763:Shigella flexneri / Q000187:drug effects; D013307:Streptomycin / Q000494:pharmacology / Q000627:therapeutic use; D013752:Tetracycline / Q000494:pharmacology / Q000627:therapeutic use
D007612:Kanamycin; D002701:Chloramphenicol; D013752:Tetracycline; D012293:Rifampin; D013307:Streptomycin